Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Sarcoma 211Bone Neoplasms 58Breast Neoplasms 40Neoplasms 39Osteosarcoma 37Lymphoma 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Gastrointestinal Stromal Tumors 31Dendritic Cell Sarcoma, Interdigitating 31Hodgkin Disease 29Lymphoma, Non-Hodgkin 27Leukemia 27Burkitt Lymphoma 25Melanoma 24Brain Neoplasms 24Multiple Myeloma 23Leukemia, Myeloid, Acute 23Sarcoma, Ewing 22Recurrence 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Glioblastoma 21Neuroblastoma 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large-Cell, Immunoblastic 18Gliosarcoma 18Sarcoma, Kaposi 17Prostatic Neoplasms 17Pancreatic Neoplasms 17

Interventions

delta 24-sterol reductase 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Osteitis Deformans × Sarcoma × Clear all
NCT01882231 2017-05-08

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
6 enrolled
Sarcoma

Bone Neoplasms, Osteitis Deformans, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡